Abstract:Type I () infection causes severe gastric inflammation and is a predisposing factor for gastric carcinogenesis. However, its infection status in stepwise gastric disease progression in this gastric cancer prevalent area has not been evaluated; it is also not known its impact on commonly used epidemiological gastric cancer risk markers such as gastrin-17 (G-17) and pepsinogens (PGs) during clinical practice.To explore the prevalence of type I and type II infection status and their impact on G-17 and PG levels in clinical practice.Thirty-five hundred and seventy-two hospital admitted patients with upper gastrointestinal symptoms were examined, and 523 patients were enrolled in this study. infection was confirmed by both C-urea breath test and serological assay. Patients were divided into non-atrophic gastritis (NAG), non-atrophic gastritis with erosion (NAGE), chronic atrophic gastritis (CAG), peptic ulcers (PU) and gastric cancer (GC) groups. Their serological G-17, PG I and PG II values and PG I/PG II ratio were also measured.A total infection rate of 3572 examined patients was 75.9%, the infection rate of 523 enrolled patients was 76.9%, among which type I infection accounted for 72.4% (291/402) and type II was 27.6%; 88.4% of GC patients were positive, and 84.2% of them were type I infection, only 11.6% of GC patients were negative. Infection rates of type I in NAG, NAGE, CAG, PU and GC groups were 67.9%, 62.7%, 79.7%, 77.6% and 84.2%, respectively. infection resulted in significantly higher G-17 and PG II values and decreased PG I/PG II ratio. Both types of induced higher G-17 level, but type I strain infection resulted in an increased PG II level and decreased PG I/PG II ratio in NAG, NAGE and CAG groups over uninfected controls. Overall PG I levels showed no difference among all disease groups and in the presence or absence of in stratified analysis, its level was increased in GC and PU patients in and type I positive groups.Type I infection is the major form of infection in this geographic region, and a very low percentage (11.6%) of GC patients are not infected by . Both types of induce an increase in G-17 level, while type I is the major strain that affects PG I and PG IIs level and PG I/PG II ratio in stepwise chronic gastric disease. The data provide insights into infection status and indicate the necessity and urgency for bacteria eradication and disease prevention in clinical practice.

The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach

Distribution of H.pylori Antigens in Gastric Mucosa and Its Significance.

Detection of H.pylori DNA in Gastric Epithelial Cells by in Situ Hybridization.

Influence of Helicobacter pylori Infection on Diagnostic Performance of Serum Pepsinogens

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection

Identification of serologically active Helicobacter pylori antigens related to alterations in serum pepsinogen levels

Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection

Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori

Analysis of long-term serological and histological changes after eradication of Helicobacter pylori

Pepsinogen II in gastritis and Helicobacter pylori infection

Serum pepsinogen II levels are doubled with <i>Helicobacter pylori</i> infection in an asymptomatic population of 40,383 Chinese subjects

Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

Serum Anti-Helicobacter Pylori Immunoglobulin G Titer Correlates with Grade of Histological Gastritis, Mucosal Bacterial Density, and Levels of Serum Biomarkers.

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects

A Retrospective Study Assessing the Acceleration Effect of Type I Helicobacter Pylori Infection on the Progress of Atrophic Gastritis.

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Helicobacter pylori Immunoproteomic Profiles in Gastric Cancer

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population

Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area